| Uterine Corpus Leiomyosarcoma studied in …STUDIED_INderived22 of 22show fewer |
|---|
| → studied in | NCT06524583Phase 2 · recruiting Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012297Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07467772Phase 2 · recruiting Ph 2 Elacestrant in ER Positive Uterine Sarcomas · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200443Phase 2 · active not recruiting Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01793168recruiting Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02428192Phase 2 · completed Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03926936Phase 2 · completed FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06244251NA · active not recruiting Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958580NA · terminated Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04935333unknown Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01533207Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01220609Phase 2 · completed Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025220Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00378911Phase 2 · completed Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01637961Phase 2 · completed Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659360Phase 2 · completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031629Phase 2 · completed Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00897442completed Collecting Tumor Samples From Patients With Gynecological Tumors · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00614835NA · completed Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390234Phase 2 · completed Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |